JP Morgan Chase
APRE icon

JP Morgan Chase’s Aprea Therapeutics APRE Stock Holding History

JP Morgan Chase’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$20 – 7050
2025
Q1 		$20 Sell
10
-1
-9% -$3 ﹤0.01% 7122
2024
Q4 		$36 Hold
11
– – ﹤0.01% 7185
2024
Q3 		$30 Sell
11
-1
-8% -$4 ﹤0.01% 7197
2024
Q2 		$49 Buy
+12
New +$62 ﹤0.01% 7032
2024
Q1 		– Sell
-5
Closed -$24 – 7382
2023
Q4 		$24 Buy
5
+1
+25% +$4 ﹤0.01% 7314
2023
Q3 		$17 Buy
+4
New +$15 ﹤0.01% 7201
2023
Q1 		– Hold
0
– – – 6663
2022
Q4 		– Hold
0
– – – 6519
2022
Q3 		– Hold
0
– – – 6439
2022
Q2 		– Sell
-1,475
Closed -$34K – 6439
2022
Q1 		$55K Sell
1,475
-8,266
-85% -$339K ﹤0.01% 5762
2021
Q4 		$559K Buy
9,741
+442
+5% +$39K ﹤0.01% 4755
2021
Q3 		$951K Buy
9,299
+6,283
+208% +$571K ﹤0.01% 4349
2021
Q2 		$294K Buy
3,016
+2,188
+264% +$202K ﹤0.01% 5030
2021
Q1 		$85K Buy
828
+656
+381% +$76.5K ﹤0.01% 5413
2020
Q4 		$16K Buy
172
+38
+28% +$18.1K ﹤0.01% 5331
2020
Q3 		$61K Buy
134
+13
+11% +$7.28K ﹤0.01% 4885
2020
Q2 		$94K Sell
121
-34
-22% -$22.3K ﹤0.01% 4601
2020
Q1 		$108K Buy
155
+50
+48% +$36.7K ﹤0.01% 4491
2019
Q4 		$97K Buy
+105
New +$57.8K ﹤0.01% 4910

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase's APRE Position: Q2 2025 in Review

JP Morgan Chase sold out of Aprea Therapeutics (APRE) in Q2 2025, closing a stake of 10 shares — an estimated $20 sold.

JP Morgan Chase first reported a position in APRE in Q4 2019 and held it in 16 quarters. The position peaked at $951K in Q3 2021. 23 funds tracked by Wall St. Rank hold APRE as of Q2 2025.

  • JP Morgan Chase reported no remaining Aprea Therapeutics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 10 Aprea Therapeutics shares in Q2 2025, an estimated $20.
  • JP Morgan Chase first reported a position in Aprea Therapeutics in Q4 2019 and held it in 16 quarters.
  • JP Morgan Chase's Aprea Therapeutics position peaked at $951K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.